Gujarat Themis Biosyn Peer Comparison

Gujarat Themis Biosyn Ltd. struggles in comparison to its peers in profitability and growth metrics. It shows no revenue or profitability growth, making it an underperformer in the sector. In contrast, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong financial metrics, particularly in profitability and valuation, positioning them as sector leaders.

• • Gujarat Themis Biosyn Ltd. shows no revenue or profitability growth, with a PE ratio significantly higher than peers.
• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong profitability metrics and attractive valuations.
• • Companies like Sun Pharmaceutical Industries and Torrent Pharmaceuticals have robust growth but trade at higher valuations.

• • Cipla Ltd.: Strong revenue growth (YoY 13.28%), high ROE (16.63%), and attractive valuation (PE 23.73).
• • Dr. Reddy's Laboratories Ltd.: Solid profitability with ROE (21.76%) and favorable valuation metrics (PE 15.50).
• • Mankind Pharma Ltd.: Exceptional revenue growth (YoY 18.12%) and strong ROE (23.15%) despite higher PE (55.18).